Table of Content:
Pharmacosmos’ sale of products is made according to the applicable price schedule or other price quotations confirmed by Pharmacosmos. The prices quoted are exclusive of V.A.T. and all other taxes, duties and fees charged or levied on goods both in Denmark and abroad.
Back to Table of Content
Payment shall be made in accordance with the conditions on the invoice. If payment is received later than the time stated, penalty interest will accrue at the rate of 7% above the official rate fixed by Denmark’s National Bank.
Buyer shall not be entitled to withhold or offset payment due to any claims.
Pharmacosmos shall be entitled to withhold any future deliveries based on anticipated breach of contract until all debts are settled.
3. Title Retention
Ownership to the goods sold is reserved for Pharmacosmos until complete payment of the price and interest and/or costs incurred have been paid.
Buyer is thus obliged to keep the goods segregated from other goods andto identity the goods as Pharmacosmos’ property.
4. Delivery Time
Pharmacosmos shall incur no liability for any claims as a consequence of delays in delivery unless otherwise agreed in writing. The delivery time stated will in the event of strikes, lock-outs, war, mobilizations, etc. be deferrable by a number of days corresponding to the duration of the setback. Delivery thus deferred is in all respects regarded as being effected in due time.
Pharmacosmos shall incur no liability in case of later delivery or nondelivery.
5. Place of Delivery and Dispatch
Unless otherwise agreed delivery shall take place CIF (for sea freight) or CIP as defined in Incoterms 2010.
Unless otherwise expressly stated by Pharmacosmos, goods are delivered in Pharmacosmos’ normal packing as included in the price. Should Buyer require special packing, payment herefore shall be made separately.
If Pharmacosmos has undertaken to ensure dispatch from the place of delivery, dispatch takes place in compliance with Buyer’s instructions and at Buyer’s risk. Buyer likewise bears any risk involved in procuring transportation facilities.
If Buyer fails to instruct Pharmacosmos in due time as to how transportation shall be effected, Pharmacosmos may choose some suitable means of transport at its own discretion. Buyer holds responsibility and risk for dispatch. Buyer shall obtain the requisite export and import permits and further ensure compliance with all conditions pertinent to import into the country of destination.
The risk of the goods is transferred to Buyer upon delivery in accordance with Incoterms 2010.
6. Quantity of Delivery
The measures, weights, and quantities indicated in the delivery notes shall govern for invoicing and settlement. Immediately on delivery Buyer shall examine whether the measure, weights and quantity of the goods are in accordance with the delivery notes. Any claims regarding measure, weight or quantity of delivery are to be made in writing right after completion of the examination.
Immediately on delivery Buyer shall examine whether the goods are in accordance with the agreed specifications. Any complaints shall be made immediately. With respect to latent defects, Buyer shall have notified Pharmacosmos immediately on discovery or at the latest 1 year after delivery otherwise the Buyer will loose the right to redelivery, repair or a credit note.
Any products or components thereof which, in Pharmacosmos’ judgment, fail to meet the specifications, shall at Pharmacosmos’ option either be repaired or replaced by Pharmacosmos at no charge to Buyer, or Pharmacosmos shall issue a credit note for any such products to the amount of the original invoice price.
Pharmacosmos’ obligations shall be limited solely to repair, replacement of the products or components thereof or issue of a credit note.
Products, which Pharmacosmos consents or directs in writing to be returned, shall be returned freight pre-paid by Pharmacosmos to Pharmacosmos or such other destination directed by Pharmacosmos. Pharmacosmos shall decide means of transportation (e.g. by ship, air, truck) and forwarding agent in each case.
Except as expressly set forth, Pharmacosmos makes no representation, statement of fact, promise or warranty of any kind or nature, express or implied, with respect to the product or its merchantability or fitness for a particular purpose.
Pharmacosmos shall not be liable towards Buyer except where Buyer’s loss is caused by proven gross negligence or willful misconduct of Pharmacosmos. Pharmacosmos shall not be liable for or be entitled to damages in the nature of incidental, consequential, special, indirect or exemplary damages, or lost profits, relating to or arising out of performance or non-performance, whether such damages are based on contract, negligence, warranty or otherwise.
Pharmacosmos shall incur no liability in case of recall of Products.
9. Product Liability
Pharmacosmos is not liable for personal or material damage caused to Buyer or Buyer’s property by the product delivered.
If such damage is caused to third parties or third parties’ property, Pharmacosmos is only liable in accordance with the Danish Product Liability Act. The Buyer shall indemnify and hold Pharmacosmos harmless for any third party damage claim, which in same way goes beyond the Danish Product Liability Act. If a third party raises such claim against Buyer, Buyer has no recourse against Pharmacosmos.
Pharmacosmos shall not be liable for any damage caused by incorrect storage or treatment, or treatment that is not as prescribed, experimental use or use in any abnormal connection.
Irrespective of the above, the maximum amount, for which Pharmacosmos can be held liable, is DKK 1 million per incident.
Any information given by Pharmacosmos is given to the best of Pharmacosmos’ experience and knowledge. However, Pharmacosmos does not guarantee any results or warrants that any third parties’ rights are not infringed, unless agreed specifically in writing.
11. Governing Law and Choice of Venue
Any dispute arising out of or in connection with this Agreement, including any disputes regarding the existence, validity or termination, shall be settled amicably.
If settlement cannot be reached, the courts of Denmark have exclusive jurisdiction.
Pharmacosmos has the option to instigate league proceedings at Buyer’s jurisdiction in case of Buyer’s non-fulfillment of payment.
The Agreement shall be governed exclusively by substantive Danish Law excluding CISG.
Terms as of February 2012
T: +45 59 48 59 59
F: +45 59 48 59 60
Pharmacosmos is the only dextran manufacturer holding certificates from the US FDA and European Directorate for the Quality of Medicines (EDQM)
Pharmacosmos delivers a unique dextran quality through a production technology that completely avoids the use of organic solvents and a quality system that meets the strictest cGMP standards for human medicines
Pharmacosmos sells and ships directly to clients everywhere in the World. We deliver Pharmaceutical Quality Dextran of the highest standards, including those of the European Pharmacopoeia (EP), the United States Pharmacopoeia (USP), and the Japanese Pharmacopoeia (JP).